TFEB at a glance

2016/06/02 by Gennaro Napolitano, Andrea Ballabio · 32 citations
Medicine · Biochemistry, Genetics and Molecular Biology · Agricultural and Biological Sciences · #Autophagy in Disease and Therapy #Cellular transport and secretion #Plant Molecular Biology Research

paper · doi:10.1242/jcs.146365

Abstract

The transcription factor EB (TFEB) plays a pivotal role in the regulation of basic cellular processes, such as lysosomal biogenesis and autophagy. The subcellular localization and activity of TFEB are regulated by mechanistic target of rapamycin (mTOR)-mediated phosphorylation, which occurs at the lysosomal surface. Phosphorylated TFEB is retained in the cytoplasm, whereas dephosphorylated TFEB translocates to the nucleus to induce the transcription of target genes. Thus, a lysosome-to-nucleus signaling pathway regulates cellular energy metabolism through TFEB. Recently, in vivo studies have revealed that TFEB is also involved in physiological processes, such as lipid catabolism. TFEB has attracted a lot of attention owing to its ability to induce the intracellular clearance of pathogenic factors in a variety of murine models of disease, such as Parkinson's and Alzheimer's, suggesting that novel therapeutic strategies could be based on the modulation of TFEB activity. In this Cell Science at a Glance article and accompanying poster, we present an overview of the latest research on TFEB function and its implication in human diseases.

Cited by

• Dysregulation of autophagy as a common mechanism in lysosomal storage diseases
• Presenilin deficiency beyond amyloid: Lessons from presenilin 1/2 conditional double-knockout mice on synaptic failure, calcium dyshomeostasis, and inflammation-driven Alzheimer’s disease
• Autophagic flux blockade under hypocapnia reveals CO2-sensitive regulation of autophagy-lysosome homeostasis
• Lysosomal homeostasis at the crossroads of neurodegeneration
• Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance
• Amyloid precursor protein and endosomal‐lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease
• Small-molecule Activation of TFEB Alleviates Niemann-Pick Disease Type C via Promoting Lysosomal Exocytosis and Biogenesis
• TRIMs and Galectins Globally Cooperate and TRIM16 and Galectin-3 Co-direct Autophagy in Endomembrane Damage Homeostasis. [europepmc]
• Heparanase: From basic research to therapeutic applications in cancer and inflammation. [europepmc]
• Tracking the embryonic stem cell transition from ground state pluripotency. [europepmc]
• Amyloid precursor protein and endosomal-lysosomal dysfunction in Alzheimer's disease: inseparable partners in a multifactorial disease. [europepmc]
• Mitophagy and Quality Control Mechanisms in Mitochondrial Maintenance. [europepmc]
• Galectins Control mTOR in Response to Endomembrane Damage. [europepmc]
• Lysosome trafficking and signaling in health and neurodegenerative diseases. [europepmc]
• mTOR-dependent phosphorylation controls TFEB nuclear export. [europepmc]
• Biological Functions of Autophagy Genes: A Disease Perspective. [europepmc]
• Brain tyrosinase overexpression implicates age-dependent neuromelanin production in Parkinson's disease pathogenesis. [europepmc]
• Membrane Lipid Composition: Effect on Membrane and Organelle Structure, Function and Compartmentalization and Therapeutic Avenues. [europepmc]
• Polyamines Control eIF5A Hypusination, TFEB Translation, and Autophagy to Reverse B Cell Senescence. [europepmc]
• Lipid Droplets and the Management of Cellular Stress. [europepmc]
• The Emerging Roles of mTORC1 in Macromanaging Autophagy. [europepmc]
• Galectin-3 Coordinates a Cellular System for Lysosomal Repair and Removal. [europepmc]
• Life in the lumen: The multivesicular endosome. [europepmc]
• Interplay Between Lipid Metabolism and Autophagy. [europepmc]
• Selective autophagy of intracellular organelles: recent research advances. [europepmc]
• Arsenic trioxide induces macrophage autophagy and atheroprotection by regulating ROS-dependent TFEB nuclear translocation and AKT/mTOR pathway. [europepmc]
• Autophagy in inflammation, infection, and immunometabolism. [europepmc]
• AMPK-dependent phosphorylation is required for transcriptional activation of TFEB and TFE3. [europepmc]
• The mTOR-Autophagy Axis and the Control of Metabolism. [europepmc]
• Machinery, regulation and pathophysiological implications of autophagosome maturation. [europepmc]
• Targeting lysosomes in human disease: from basic research to clinical applications. [europepmc]
• Impairment of the autophagy-lysosomal pathway in Alzheimer's diseases: Pathogenic mechanisms and therapeutic potential. [europepmc]

Related

• Small-molecule Activation of TFEB Alleviates Niemann-Pick Disease Type C via Promoting Lysosomal Exocytosis and Biogenesis
• Lactylation stabilizes TFEB to elevate autophagy and lysosomal activity
• Skeletal muscle TFEB overexpression does not increase neurogenesis markers in the young female hippocampus
• Mitochondrial and lysosomal biogenesis are activated following <scp>PINK</scp>1/parkin‐mediated mitophagy
• Alpha-synuclein, autophagy-lysosomal pathway, and Lewy bodies: Mutations, propagation, aggregation, and the formation of inclusions